期刊文献+

胺碘酮联合美托洛尔治疗收缩性心力衰竭合并心律失常的效果观察 被引量:28

Effect observation of amiodarone combined with metoprolol in the treatment of systolic heart failure and arrhythmia
下载PDF
导出
摘要 目的评价胺碘酮联合美托洛尔治疗收缩性心力衰竭合并心律失常的效果。方法选取2010年3月~2013年2月本院收治的34例收缩性心力衰竭合并心律失常患者,随机分为两组,各17例,对照组采用胺碘酮治疗,观察组采用胺碘酮联合美托洛尔治疗,比较两组的临床疗效、左心室射血分数、心率及不良反应发生率。结果观察组的总有效率为94.12%,对照组的总有效率为82.35%,差异有统计学意义(P〈0.05);观察组治疗后的左心室射血分数高于对照组,心率慢于对照组,差异有统计学意义(P〈0.05);观察组的不良反应发生率为5.88%,对照组的不良反应发生率为17.65%,差异有统计学意义(P〈0.05)。结论胺碘酮联合美托洛尔治疗收缩性心力衰竭合并心律失常效果好,安全系数高,值得临床推广应用。 Objective To evaluate the efficacy of amiodarone combined with metoprolol in the treatment of systolic heart failure and arrhythmia.Methods 34 patients with systolic heart failure and arrhythmia admitted and treated in our hospital from March 2010 to February 2013 were selected and randomly assigned to two groups,each group of 17 cases. Amiodarone was used in control group,amiodarone combined with metoprolol were used in observation group.Clinical efficacy,left ventricular ejection fraction,heart rate and incidence rate of adverse reaction was compared in two goups respectively.Results Total effective rate of observation group and control group was 94.12% and 82.35% respectively,with statistical difference(P0.05).After treatment,left ventricular ejection fraction of observation group was higher than that of control group,heart rate of observation group was slower than that of control group,with statistical difference(P0.05). Incidence rate of adverse reaction in observation group and control group was 5.88% and 17.65% respectively,with statistical difference(P0.05).Conclusion Amiodarone combined with metoprolol in the treatment of systolic heart failure and arrhythmia has good efficacy and safety,which is worthy of clinical promotion and application.
出处 《中国当代医药》 2014年第6期76-77,79,共3页 China Modern Medicine
关键词 胺碘酮 美托洛尔 心力衰竭 心律失常 Amiodarone Metoprolol Heart failure Arrhythmia
  • 相关文献

参考文献11

二级参考文献61

  • 1蒋文平.胺碘酮抗心律失常治疗应用指南[J].中华心血管病杂志,2004,32(12):1065-1071. 被引量:142
  • 2胡大一,周玉杰.心血管病学[M].北京:人民卫生出版社,2009:1310-1311.
  • 3Frommeyer G,Schmidt M,Clau C Further insights into the unde-rlying electrophysiological mechanisms for reduction of atrialfibrillation by ranolazine in an experimental model of chronicheart failure[J].Eur J Heart Fail,2012,14(12):1322-1331.
  • 4Bardy GH, hee KL, Mark DB, el al. Amiodarone or an implanlable cardioener- defibrillator for congeslive failure[JI.N Engl J Med, 2005;352(3):225-37.
  • 5中华医学会心血管病学分会,中国生物医学工程学会心律分会,胺碘酮康心理失常治疗应用指南工作组胺碘酮抗心律失常治疗应川指南(2008)[J].中华心血管编杂志,2008;36(9):769-777.
  • 6裘健.胺碘酮治疗老年警性心律灾常患者的临味疗敛歧安全性分析[J].中国陕药导刊,2011:13(5):768-769.
  • 7Bente B, Hanne Eo Li J. et al. QT dispersion has no prognostic information of patients with advanced congestive heart failure and redueed left ventrieular systolie [J]. Circulation, 2001, 103: 831-835.
  • 8Roy D, Talajic M, Dorian P, et al. Amiodalone to prevent recur- rence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators [J]. N Engl Med, 2002,342 (13) : 913-920.
  • 9林威,于东汇,李东镐,等.胺碘酮治疗充血性心力衰竭临床分析[J].中国使实用医药,2012,7(18):40-41.
  • 10贺文德,董爱莲.胺碘酮治疗充血性心力衰竭合并室性心律失常疗效观察[J].中国药物经济学,2012,7(6):136-137.

共引文献71

同被引文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部